Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Progress in Cardiovascular Diseases|October 18, 2024
The ventilatory efficiency parameters outperform peak oxygen consumption in monitoring the therapy effects in patients with hypertrophic cardiomyopathyStefan Seman, Milorad Tesic, Marija Babic, et al.
European Journal of Heart Failure|May 27, 2024
Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM)Lazar Velicki, Dejana Popovic, Nduka C Okwose, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Enhanced Cardiac CaMKII Oxidation and CaMKII-Dependent SR Ca Leak in Patients with Sleep-Disordered BreathingMichael Arzt, Marzena A Drzymalski, Sarah Ripfel, et al.
BMC Cardiovascular Disorders|December 10, 2020
Genetic determinants of clinical phenotype in hypertrophic cardiomyopathyLazar Velicki, Djordje G Jakovljevic, Andrej Preveden, et al.
European Journal of Heart Failure|October 31, 2025
Left ventricular transthyretin amyloid load and apical sparing in patients with newly confirmed transthyretin amyloid cardiomyopathyThomas Krammer, Maria J Baier, Vanessa Lutz, et al.
BMJ Open|January 8, 2025
Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal studySarah Jane Charman, Nduka C Okwose, Amy Groenewegen, et al.
ESC Heart Failure|November 26, 2025
Economic burden of heart failure in Europe: A systematic review of costs and cost-effectivenessJosep Darbà, Meritxell Ascanio, Antonio Rodríguez, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 26, 2026
Current treatment decisions in cardiac transthyretin amyloidosis: a multicentre analysisDaniel Lavall, Katharina Knoll, Sebastian Spethmann, et al.
Pageof 3